packageIxekizumab

ixekizumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ixekizumab is a monoclonal antibody used to treat psoriasis, psoriatic arthritis, axial spondyloarthritis, and juvenile arthritis. It is an approved interleukin inhibitor authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q13574436 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ixekizumab
ATC codes:L04AC13
DrugBank:DB11569
Wikidata:Q13574436
molar mass:146158 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown